Suchergebnisse - (Standardsuche:ritonavir)

PubPharm (56)

1

Nirmatrelvir/ritonavir drug-drug interactions in primary care outpatients

enthalten in: Anales del sistema sanitario de Navarra | 2023

von Rodríguez Esquíroz, A. | Sanz Álvarez, L. | Marín Marín, M. | +3

2

Mild SARS-CoV-2 infection in vulnerable patients : implementation of a clinical pathway for early treatment

enthalten in: Enfermedades infecciosas y microbiologia clinica | 2022

von Pinargote-Celorio, H. | Otero-Rodríguez, S. | González-de-la-Aleja, P. | +11

3

QTc interval prolongation in patients infected with SARS-CoV-2 and treated with antiviral drugs

enthalten in: Anales de pediatria (Barcelona, Spain : 2003) | 2022

von Esmel-Vilomara, R. | Dolader, P. | Sabaté-Rotes, A. | +3

4

QTc interval prolongation in patients infected with SARS-CoV-2 and treated with antiviral drugs

enthalten in: Anales de pediatria | 2021

von Esmel-Vilomara, R. | Dolader, P. | Sabaté-Rotes, A. | +3

5

Clinical characteristics of patients hospitalized with COVID-19 in Spain : Results from the SEMI-COVID-19 Registry

enthalten in: Revista clinica espanola | 2020

von Casas-Rojo, J. | Antón-Santos, J. | Millán-Núñez-Cortés, J. | +23

CommentIn: Rev Clin Esp (Barc). 2021 May;221(5):311-312. - PMID 33998521

6

Boosted protease inhibitor monotherapy in HIV-infected patients : results of a study in a real life setting

enthalten in: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia | 2015

von Di Benedetto, N. | Montero-Alonso, M. | Blanes, M. | +5

7

Initial antiretroviral treatment in human immunodeficiency virus-infected patients in Spain : Decisions made in relation to particular immunovirological characteristics (PERFIL-es study)

enthalten in: Enfermedades infecciosas y microbiologia clinica | 2014

von Viciana, P. | Ocampo, A. | Hevia, H. | +2

8

Consensus Statement by GeSIDA/National AIDS Plan Secretariat on antiretroviral treatment in adults infected by the human immunodeficiency virus (Updated January 2013)

enthalten in: Enfermedades infecciosas y microbiologia clinica | 2013

von Panel de expertos de GeSIDA y Plan Nacional sobre el Sida

9

Comparative cost-effectiveness analysis between darunavir/ritonavir and other protease inhibitors in treatment-naive human immunodeficiency syndrome type 1-infected patients in Spain

enthalten in: Enfermedades infecciosas y microbiologia clinica | 2013

von Smets, E. | Brogan, A. | Hill, A. | +5

10

New strategies in the optimisation of lopinavir/ritonavir doses in human immunodeficiency virus-infected patients

enthalten in: Enfermedades infecciosas y microbiologia clinica | 2013

von López Aspiroz, E. | Cabrera Figueroa, S. | Domínguez-Gil Hurlé, A. | +1

1
2
3
4
5
6
Nächster »
[6]